Cybin Inc. (HELP)
NASDAQ: HELP · Real-Time Price · USD
12.81
+0.22 (1.75%)
Sep 29, 2026, 12:28 PM EDT - Market open
Cybin Market Cap
Cybin has a market cap or net worth of $935.9 million as of September 29, 2026. Its market cap has increased by 533.83% in one year.
Market Cap
935.90M
Enterprise Value
769.54M
1-Year Change
533.83%
Ranking
Category
Stock Price
$12.81
ChartMarket Cap Chart
Since November 11, 2020, Cybin's market cap has increased from $91.10M to $935.90M, an increase of 927.38%. That is a compound annual growth rate of 48.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 935.90M | 129.27% |
| Dec 31, 2025 | 408.21M | 131.40% |
| Dec 31, 2024 | 176.41M | 4.62% |
| Dec 29, 2023 | 168.63M | 199.71% |
| Dec 30, 2022 | 56.26M | -72.57% |
| Dec 31, 2021 | 205.14M | 4.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Corvus Pharmaceuticals | 977.49M |
| Arbutus Biopharma | 959.56M |
| Kura Oncology | 957.22M |
| Cullinan Therapeutics | 953.09M |
| Alumis | 918.99M |
| Jade Biosciences | 917.07M |
| SpyGlass Pharma | 905.44M |
| Rigel Pharmaceuticals | 900.00M |